Previous work has shown that heterozygocity for a null mutation of the VEGF-A gene, resulting in a 50% reduction in VEGF-A expression, is embryonic lethal at embroyonic day (E) 9.5 in mice. We now show that two- to threefold overexpression of VEGF-A from its endogenous locus results in severe abnormalities in heart development and embryonic lethality at E12.5-E14. The mutant embryos displayed an attenuated compact layer of myocardium, overproduction of trabeculae, defective ventricular septation and abnormalities in remodeling of the outflow track of the heart. In addition, aberrant coronary development was characterized by formation of oversized epicardial vessels, apparently through vasculogenesis. We infer that embryonic survival requires a narrow window of VEGF-A expression.

Baumgartner
I.
,
Pieczek
A.
,
Manor
O.
,
Blair
R.
,
Kearney
M.
,
Walsh
K.
,
Isner
J. M.
(
1998
)
Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.
Circulation
97
,
1114
1123
Benjamin
L. E.
,
Golijanin
D.
,
Itin
A.
,
Pode
D.
,
Keshet
E.
(
1999
)
Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.
J. Clin. Invest
103
,
159
165
Benjamin
L. E.
,
Keshet
E.
(
1997
)
Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.
Proc. Natl. Acad. Sci. USA
94
,
8761
8766
Carmeliet
P.
,
Ferreira
V.
,
Breier
G.
,
Pollefeyt
S.
,
Kieckens
L.
,
Gertsenstein
M.
,
Fahrig
M.
,
Vandenhoeck
A.
,
Harpal
K.
,
Eberhardt
C.
, et al. 
(
1996
)
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.
Nature
380
,
439
–.
Claffey
K. P.
,
Shih
S. C.
,
Mullen
A.
,
Dziennis
S.
,
Cusick
J. L.
,
Abrams
K. R.
,
Lee
S. W.
,
Detmar
M.
(
1998
)
Identification of a human VPF/VEGF 3untranslated region mediating hypoxia-induced mRNA stability.
Mol. Biol. Cell
9
,
469
481
De Vries
C.
,
Escobedo
J. A.
,
Ueno
H.
,
Houck
K.
,
Ferrara
N.
,
Williams
L. T.
(
1992
)
The FMS-like tyrosine kinase, a receptor for vascular endothelial growth factor.
Science
255
,
989
991
Dibbens
J. A.
,
Miller
D. L.
,
Damert
A.
,
Risau
W.
,
Vadas
M. A.
,
Goodall
G. J.
(
1999
)
Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements.
Mol. Biol. Cell
10
,
907
919
Erickson
S. L.
,
O'Shea
K. S.
,
Ghaboosi
N.
,
Loverro
L.
,
Frantz
G.
,
Bauer
M.
,
Lu
L. H.
,
Moore
M. W.
(
1997
)
ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice.
Development
124
,
4999
5011
Ferrara
N.
,
Carver-Moore
K.
,
Chen
H.
,
Dowd
M.
,
Lu
L.
,
O'Shea
K. S.
,
Powell-Braxton
L.
,
Hillan
K. J.
,
Moore
M. W.
(
1996
)
Heterozygous embryonic lethality induced by targetted inactivation of the VEGF gene.
Nature
380
,
439
442
Ferrara
N.
,
Schweigerer
L.
,
Neufeld
G.
,
Mitchell
R.
,
Gospodarowicz
D.
(
1987
)
Pituitary follicular cells produce basic fibroblast growth factor.
Proc. Natl. Acad. Sci. USA
84
,
5773
5777
Feucht
M.
,
Christ
B.
,
Wilting
J.
(
1997
)
VEGF induces cardiovascular malformation and embryonic lethality.
Am. J. Pathol
151
,
1407
1416
Flamme
I.
,
von Reutern
M.
,
Drexler
H. C.
,
Syed-Ali
S.
,
Risau
W.
(
1995
)
Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation.
Dev Biol
171
,
399
414
Fong
G. H.
,
Rossant
J.
,
Gertsenstein
M.
,
Breitman
M. L.
(
1995
)
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.
Nature
376
,
66
70
Fong
G. H.
,
Zhang
L.
,
Bryce
D. M.
,
Peng
J.
(
1999
)
Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice.
Development
126
,
3015
3025
Forsythe
J. A.
,
Jiang
B. H.
,
Iyer
N. V.
,
Agani
F.
,
Leung
S. W.
,
Koos
R. D.
,
Semenza
G. L.
(
1996
)
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.
Mol. Cell. Biol
16
,
4604
4613
Gassmann
M.
,
Casagranda
F.
,
Orioli
D.
,
Simon
H.
,
Lai
C.
,
Klein
R.
,
Lemke
G.
(
1995
)
Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor.
Nature
378
,
390
394
Gerber
H. P.
,
Hillan
K. J.
,
Ryan
A. M.
,
Kowalski
J.
,
Keller
G. A.
,
Rangell
L.
,
Wright
B. D.
,
Radtke
F.
,
Aguet
M.
,
Ferrara
N.
(
1999
)
VEGF is required for growth and survival in neonatal mice.
Development
126
,
1149
1159
Ikeda
E.
,
Achen
M.
,
Breier
G.
,
Risa
W.
(
1995
)
Hypoxia-induced transcriptional activation and increased mRNA stability of VEGF in C6 glioma cells.
J. Biol. Chem
270
,
19761
19766
Jang
S. K.
,
Krausslich
H. G.
,
Nicklin
M. J.
,
Duke
G. M.
,
Palmenberg
A.C.
,
Wimmer
E.
(
1988
)
A segment of the 5nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation.
J. Virol
62
,
2636
2643
Lee
K. F.
,
Simon
H.
,
Chen
H.
,
Bates
B.
,
Hung
M. C.
,
Hauser
C.
(
1995
)
Requirement for neuregulin receptor erbB2 in neural and cardiac development.
Nature
378
,
394
398
Leung
D. W.
,
Cachianes
G.
,
Kuang
W. J.
,
Goeddel
D. V.
,
Ferrara
N.
(
1989
)
Vascular endothelial growth factor is a secreted angiogenic mitogen.
Science
246
,
1306
1309
Levy
A.
,
Levy
N.
,
Wegner
S.
,
Goldberg
M.
(
1995
)
Transcriptional regulation of the rat VEGF gene by hypoxia.
J. Biol. Chem
270
,
13333
13340
Levy
A. P.
,
Levy
N. S.
,
Goldberg
M. A.
(
1996
)
Post-transcriptional regulation of vascular endothelial growth factor by hypoxia.
J. Biol. Chem
271
,
2746
2753
Levy
N. S.
,
Goldberg
M. A.
,
Levy
A. P.
(
1997
)
Sequencing of the human vascular endothelial growth factor (VEGF) 3untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites.
Biochim. Biophys. Acta
1352
,
167
173
Liu
Y.
,
Cox
S. R.
,
Morita
T.
,
Kourembanas
S.
(
1995
)
Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells.
Identification of a 5enhancer. Circ. Res
77
,
638
643
Lobe
C. G.
,
Koop
K. E.
,
Kreppner
W.
,
Lomeli
H.
,
Gertsenstein
M.
,
Nagy
A.
(
1999
)
Z/AP, a double reporter for cre-mediated recombination.
Dev. Biol
208
,
281
292
Lobe
C. G.
,
Nagy
A.
(
1998
)
Conditional genome alteration in mice.
BioEssays
20
,
200
208
Losordo
D. W.
,
Vale
P. R.
,
Symes
J. F.
,
Dunnington
C. H.
,
Esakof
D. D.
,
Maysky
M.
,
Ashare
A. B.
,
Lathi
K.
,
Isner
J. M.
(
1998
)
Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.
Circulation
98
,
2800
2804
Meyer
D.
,
Birchmeier
C.
(
1995
)
Multiple essential functions of neuregulin in development [published erratum appears in Nature 378, 753].
Nature
378
,
386
390
Mikawa
T.
,
Fischman
D. A.
(
1992
)
Retroviral analysis of cardiac morphogenesis: discontinuous formation of coronary vessels.
Proc. Natl. Acad. Sci. USA
89
,
9504
9508
Millauer
B.
,
Wizigmann-Voos
S.
,
Schnurch
H.
,
Martinez
R.
,
Moller
N. P. H.
,
Risau
W.
,
Ullrich
A.
(
1993
)
High affinity VEGF binding and developmental expression suggest FLK-1 as a major regulator of vasculogenesis and angiogenesis.
Cell
72
,
835
846
Miquerol
L.
,
Gertsenstein
M.
,
Harpal
K.
,
Rossant
J.
,
Nagy
A.
(
1999
)
Multiple developmental roles of VEGF suggested by a LacZ-tagged allele.
Dev. Biol
212
,
307
322
Mustonen
T.
,
Alitalo
K.
(
1995
)
Endothelial receptor tyrosine kinases involved in angiogenesis.
J. Cell Biol
129
,
895
898
Nagy
A.
,
Rossant
J.
,
Nagy
R.
,
Abramow-Newerly
W.
,
Roder
J.
(
1993
)
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Proc. Natl. Acad. Sci. USA
90
,
8424
8428
Rakusan
K.
,
Cicutti
N.
,
Flanagan
M. F.
(
1994
)
Changes in the microvascular network during cardia growth, development, and aging.
Cell. Mol. Biol. Res
40
,
117
122
Rosengart
T. K.
,
Lee
L. Y.
,
Patel
S. R.
,
Sanborn
T. A.
,
Parikh
M.
,
Bergman
G. W.
,
Hachamovitch
R.
,
Szulc
M.
,
Kligfield
P. D.
,
Okin
P. M.
, et al. 
(
1999
)
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.
Circulation
100
,
468
474
Shalaby
F.
,
Rossant
J.
,
Yamaguchi
T. P.
,
Gertsenstein
M.
,
Wu
X. F.
,
Breitman
M. L.
,
Schuh
A. C.
(
1995
)
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.
Nature
376
,
62
66
Shibuya
M.
,
Yamaguchi
S.
,
Yamane
A.
,
Ikeda
T.
,
Tojo
A.
,
Matsushime
H.
,
Sato
M.
(
1990
)
Nucleotide sequence and expression of a novel Human receptor-type tyrosine kinasegene (flt) closely related to the fms family.
Oncogene
5
,
519
524
Takeuchi
T.
,
Yamazaki
Y.
,
Katoh-Fukui
Y.
,
Tsuchiya
R.
,
Kondo
S.
,
Motoyama
J.
,
Higashinakagawa
T.
(
1995
)
Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation.
Genes Dev
9
,
1211
1222
Tomanek
R. J.
,
Ratajska
A.
,
Kitten
G. T.
,
Yue
X.
,
Sandra
A.
(
1999
)
Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis.
Dev. Dyn
215
,
54
61
Tsurumi
Y.
,
Kearney
M.
,
Chen
D.
,
Silver
M.
,
Takeshita
S.
,
Yang
J.
,
Symes
J. F.
,
Isner
J. M.
(
1997
).
Circulation
96
,
382
388
This content is only available via PDF.